Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lecithin-cholesterol acyltransferase (LCAT) is a key enzyme in lipid metabolism that catalyzes the conversion of free cholesterol into cholesteryl ester, a more hydrophobic form that can be efficiently transported within lipoproteins. It plays a central role in reverse cholesterol transport, removing excess cellular cholesterol from peripheral tissues and delivering it to the liver for excretion or redistribution. Deficiency or mutations in LCAT cause rare autosomal recessive disorders such as Familial LCAT deficiency and Fish-eye disease.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lecithin-cholesterol acyltransferase (LCAT).